JACLYN MEIS: Open Payments
NPI 1831685023 · SIOUX CITY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,454 in 117 payments from 44 companies in 2025. Trend: 2023 $3,299 · 2024 $2,928 · 2025 $2,454
Food & beverage: $2,033Education: $422
| Company | Payments | Amount |
|---|---|---|
| Exelixis Inc. | 4 | $208 |
| Janssen Biotech, Inc. | 11 | $206 |
| Daiichi Sankyo Inc. | 9 | $183 |
| Merck Sharp & Dohme LLC | 11 | $175 |
| SEAGEN INC. | 2 | $174 |
| Novartis Pharmaceuticals Corporation | 8 | $154 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $112 |
| E.R. Squibb & Sons, L.L.C. | 6 | $111 |
| ABBVIE INC. | 6 | $106 |
| SERVIER PHARMACEUTICALS LLC | 4 | $89 |
Products named: Enhertu, KEYTRUDA, ENJAYMO, DARZALEX, LONSURF, EPKINLY, OPDUALAG, RYBREVANT.
Industry payments across IA — which companies pay providers there.
